1-2 of 2
Mark Joseph Axelrod
Close
Save search
Sort by
Journal Articles

The Combination of Entospletinib and Vincristine Demonstrates Synergistic Activity in a Broad Panel of Hematological Cancer Cell Lines and Anti-Tumor Efficacy in a DLBCL Xenograft Model

Free
Mark Joseph Axelrod, PhD, Peter Fowles, Jeff Silverman, PhD, Astrid Clarke, PhD, Jennifer Tang, Emma Rousseau, M.S., Heather Kay Webb, PhD, Julie Di Paolo, PhD
Journal: Blood
Blood (2015) 126 (23): 5123.
https://doi.org/10.1182/blood.V126.23.5123.5123
Published: 2015
Journal Articles

Combination Effects of B Cell Receptor Pathway Inhibitors (Entospletinib, ONO/GS-4059, and Idelalisib) and a BCL-2 Inhibitor in Primary CLL Cells

Free
Randall Jones, B.A., Mark Joseph Axelrod, PhD, Daniel Tumas, PhD DVM, Christophe Quéva, PhD, Julie Di Paolo, PhD
Journal: Blood
Blood (2015) 126 (23): 1749.
https://doi.org/10.1182/blood.V126.23.1749.1749
Published: 2015